Cargando…
Bridging the Racial Disparity Gap in Lipid‐Lowering Therapy
Autor principal: | Kalra, Dinesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955462/ https://www.ncbi.nlm.nih.gov/pubmed/33325243 http://dx.doi.org/10.1161/JAHA.120.019533 |
Ejemplares similares
-
Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021) -
Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis
por: Patel, Parita, et al.
Publicado: (2020) -
Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Khan, Safi U., et al.
Publicado: (2019) -
Effects of novel glucose-lowering drugs on the lipid parameters: A systematic review and meta-analysis
por: Dar, Sophia, et al.
Publicado: (2022) -
Network Meta‐Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid‐Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low‐Density Lipoprotein Cholesterol
por: Toth, Peter P., et al.
Publicado: (2022)